Furthermore, FOXO1 ́s negative regulatory influence on skeletal muscle mass and type I fibre gene expression has been proposed, potentially contributing to sarcopenia, obesity, and diabetes in humans [25]. The gene discussed is FOXO1; the disease is sarcopenia.